FDA Approves von Willebrand Factor (Recombinant) as Prophylaxis for Adults with Severe Type 3 Disease
Summary : In a clinical trial, the median annualized bleeding rates for all bleeds was reduced from a historical median of 5…
Summary : In a clinical trial, the median annualized bleeding rates for all bleeds was reduced from a historical median of 5…
Synopsis : ViiV Healthcare’s HIV treatment Cabenuva has been approved by the U.S. Food and Drug Administration for use every two months,…
Synopsis :: -ImmunityBio shared positive results from the clinical trial of its IL-15 superagonist Anktiva (N-803) to treat people living with human…
Summary : Panacea Biotec Pharma is a subsidiary of vaccine maker Panacea Biotec; its domestic biz had a turnover of Rs 219…
Synopsis : Autonomous vehicle industry veteran will build on early success to lead operational growth, oversee geographic expansion, and spearhead Embark’s commercialization…
Summary : Pfizer and Ionis Pharmaceuticals announced that the former is abandoning its vupanorsen program for cardiovascular (CV) risk reduction and severe…
Synopsis : Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for fatty liver diseases, announced today that Dr. Dominic F.…
Synopsis : Shares of Madrigal Pharmaceuticals went up in premarket trading after the company announced positive topline data from its Phase III…
Summary : One week after Johnna Rossell departed Biogen for Enzyvant, the embattled company announced that two members of its board of…
Today, the U.S. Food and Drug Administration approved a second COVID-19 vaccine. The vaccine has been known as the Moderna COVID-19 Vaccine;…